Wang W, Hao X, Lv X, Li Y, Xing W, Chen T
Sci Rep. 2025; 15(1):8890.
PMID: 40087327
DOI: 10.1038/s41598-025-92827-7.
Rakoczy K, Szymanska N, Stecko J, Kisiel M, Sleziak J, Gajewska-Naryniecka A
Cells. 2025; 14(5).
PMID: 40072059
PMC: 11899714.
DOI: 10.3390/cells14050330.
Guo Q, Qin H, Chen Z, Zhang W, Zheng L, Qin T
Genes Dis. 2025; 12(3):101311.
PMID: 40034124
PMC: 11875185.
DOI: 10.1016/j.gendis.2024.101311.
Yan B, Lu Q, Gao T, Xiao K, Zong Q, Lv H
Cell Death Dis. 2025; 16(1):150.
PMID: 40032820
PMC: 11876685.
DOI: 10.1038/s41419-025-07470-x.
Minami M, Sakoda T, Kawano G, Kochi Y, Sasaki K, Sugio T
Leukemia. 2025; .
PMID: 39979604
DOI: 10.1038/s41375-025-02530-9.
Farnesoid X Receptor Attenuates the Tumorigenicity of Liver Cancer Stem Cells by Inhibiting STAT3 Phosphorylation.
Ye W, Zhao Y, Wang Y, Wang Y, Zhang H, Wang F
Int J Mol Sci. 2025; 26(3).
PMID: 39940889
PMC: 11817294.
DOI: 10.3390/ijms26031122.
The mitochondria as an emerging target of self-renewal in T-cell acute lymphoblastic leukemia.
Al-Hamaly M, Winter E, Blackburn J
Cancer Biol Ther. 2025; 26(1):2460252.
PMID: 39905687
PMC: 11801350.
DOI: 10.1080/15384047.2025.2460252.
Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy.
Shao X, Zhao X, Wang B, Fan J, Wang J, An H
Theranostics. 2025; 15(5):1689-1714.
PMID: 39897552
PMC: 11780529.
DOI: 10.7150/thno.103636.
Radioresistance in rectal cancer: can nanoparticles turn the tide?.
Coelho D, Estevao D, Oliveira M, Sarmento B
Mol Cancer. 2025; 24(1):35.
PMID: 39885557
PMC: 11784129.
DOI: 10.1186/s12943-025-02232-x.
Small Molecule Modulators of AMP-Activated Protein Kinase (AMPK) Activity and Their Potential in Cancer Therapy.
Strang J, Astridge D, Nguyen V, Reigan P
J Med Chem. 2025; 68(3):2238-2254.
PMID: 39879193
PMC: 11831681.
DOI: 10.1021/acs.jmedchem.4c02354.
models of leukemia development: the role of very small leukemic stem-like cells in the cellular transformation cascade.
Lica J, Jakobkiewicz-Banecka J, Hellmann A
Front Cell Dev Biol. 2025; 12():1463807.
PMID: 39830209
PMC: 11740207.
DOI: 10.3389/fcell.2024.1463807.
Targeting ROR2 homooligomerization disrupts ROR2-dependent signaling and suppresses stem-like cell properties of human breast adenocarcinoma.
Leng F, Huang J, Wu L, Zhang J, Lin X, Deng R
iScience. 2025; 28(1):111589.
PMID: 39829682
PMC: 11742321.
DOI: 10.1016/j.isci.2024.111589.
Microenvironmental Regulation of Dormancy in Breast Cancer Metastasis: "An Ally that Changes Allegiances".
Kabak E, Foo S, Rafaeva M, Martin I, Bentires-Alj M
Adv Exp Med Biol. 2025; 1464():373-395.
PMID: 39821034
DOI: 10.1007/978-3-031-70875-6_18.
Investigating combined hypoxia and stemness indices for prognostic transcripts in gastric cancer: Machine learning and network analysis approaches.
Mahmoudian-Hamedani S, Lotfi-Shahreza M, Nikpour P
Biochem Biophys Rep. 2025; 41():101897.
PMID: 39807391
PMC: 11729012.
DOI: 10.1016/j.bbrep.2024.101897.
FAT1 knockdown enhances the CSC properties of HNSCC through p-CaMKII-mediated inactivation of the IFN pathway.
Wang J, Chen Y, Sun Y, Liu H, Du R, Wang X
Int J Biol Sci. 2025; 21(2):671-684.
PMID: 39781458
PMC: 11705627.
DOI: 10.7150/ijbs.95723.
MicroRNA Profiling of PRELI-Modulated Exosomes and Effects on Hepatic Cancer Stem Cells.
Kim B
Int J Mol Sci. 2025; 25(24.
PMID: 39769068
PMC: 11678812.
DOI: 10.3390/ijms252413299.
Interleukin-6 Modulation in Ovarian Cancer Necessitates a Targeted Strategy: From the Approved to Emerging Therapies.
Amer H, Kampan N, Itsiopoulos C, Flanagan K, Scott C, Kartikasari A
Cancers (Basel). 2025; 16(24.
PMID: 39766086
PMC: 11674514.
DOI: 10.3390/cancers16244187.
Dissecting tumor transcriptional heterogeneity from single-cell RNA-seq data by generalized binary covariance decomposition.
Liu Y, Carbonetto P, Willwerscheid J, Oakes S, Macleod K, Stephens M
Nat Genet. 2025; 57(1):263-273.
PMID: 39747597
DOI: 10.1038/s41588-024-01997-z.
Tumor microenvironment-responsive nanoformulations for breast cancer.
Velapure P, Kansal D, Bobade C
Discov Nano. 2024; 19(1):212.
PMID: 39708097
PMC: 11663212.
DOI: 10.1186/s11671-024-04122-5.
Comprehensive review of drug resistance in mammalian cancer stem cells: implications for cancer therapy.
Mengistu B, Tsegaw T, Demessie Y, Getnet K, Bitew A, Kinde M
Cancer Cell Int. 2024; 24(1):406.
PMID: 39695669
PMC: 11657890.
DOI: 10.1186/s12935-024-03558-0.